Bis(4-nitro­phen­yl) 1,3-phenyl­ene­dimethyl­ene dicarbonate

In the title mol­ecule, C22H16N2O10, the dihedral angles between the benzene rings of the 4-nitro­phenyl groups and the central benzene ring are 32.7 (1) and 34.7 (1)°, while the dihedral angle between the two benzene rings of the 4-nitro­phenyl groups is 3.6 (2)°. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonds link mol­ecules into centrosymmetric dimers

Di-tert-butyl cyclo­hex-2-ene-1,4-diyl dicarbonate

In the title mol­ecule, C16H26O6, the central cyclo­hexene ring is in a half-chair conformation. The carbonyl groups are in a trans arrangement with respect to each other and the dihedral angle between the mean planes of the carbonate groups is 10.8 (2)°

2,5-Dimethyl­hexane-2,5-diyl bis­(4-nitro­phen­yl) dicarbonate

The title structure, C22H24N2O10, contains two independent centrosymmetric mol­ecules. The only significant difference between the mol­ecules is the dihedral angle between the unique carbonate group (–O—CO2–) and the benzene ring, the values being 77.35 (8) and 66.42 (8)°. The crystal structure is stabilized by weak inter­molecular C—H⋯O hydrogen bonds

3-Methyl-1H-pyrrolo[2,1-c][1,4]oxazin-1-one

In the title mol­ecule, C8H7NO2, all the non-H atoms lie essentially in the same plane (r.m.s. deviation = 0.019 Å) In the crystal structure, weak inter­molecular C—H⋯O inter­actions link mol­ecules into chains along [100]. In addition, there are π–π stacking inter­actions between mol­ecules related by the c-glide plane, with alternating centroid–centroid distances of 3.434 (2) and 3.639 (2) Å

trans-Cyclo­hexane-1,4-diyl bis­(4-nitro­phen­yl) dicarbonate

In the title crystal structure, C20H18N2O10, there are two independent mol­ecules, both of which lie on crystallographic inversion centres. In one mol­ecule the 4-nitro­phenyl dicarbonate groups are substituted in equatorial (A eq) positions of the chair-form cyclo­hexane ring while in the other mol­ecule the substitution is axial (B ax). The dihedral angles between the atoms of the symmetry-unique carbonate group (O=CO2—) and benzene ring for each mol­ecule are 47.3 (1)° for A eq and 11.7 (2)° for B ax. In B ax, this facilitates the formation of a weak intra­molecular C—H⋯O hydrogen bond, while the packing is stabilized by weak inter­molecular C—H⋯O inter­actions

trans-Cyclo­hex-2-ene-1,4-diyl bis­(4-nitro­phen­yl) dicarbonate

Although the title mol­ecule, C20H16N2O10, does not possess mol­ecular inversion symmetry, it lies on a crystallographic inversion centre which imposes disorder on the central cyclo­hexene ring. In addition, the cyclo­hexene ring has non-symmetry-related disorder over two sites, with the ratio of the major and minor components being 0.54:0.46. The overall effect is to produce four disorder components for the atoms of the cyclo­hexene ring. The side chain is perfectly ordered and the dihedral angle between the atoms of the carbonate group (O=CO2—) and the benzene ring is 72.99 (6)°

GC/GC-MS analysis and biological activities of Lantana Camara Linn.

Medicinal plants have been a part of human history for thousands of years and are still used as healthcare throughout the world. The current research aims to explore the chemical constituents of the methanol soluble extract (LC-Me) and petroleum ether soluble fraction (LCM-PES) from the leaves of Lantana camara Linn by GC/ GC-MS. This chemical analysis revealed the existence of 16 and 23 phytoconstituents in LC-Me and LCM-PES respectively. The major constituents in LC-Me were found to beethyl 9,12,15-octadecatrienoate (31.9%), hexadecanoic acid, ethyl ester (12.6%), n-hexadecanoic acid (11.1%), linoleic acid ethyl ester (9.1%), squalene (8.7%), di-n-octyl phthalate (6.2%), 9,12-octadecadienoic acid (Z,Z)- (4.2%), (E)-9-octadecenoic acid ethyl ester (2.7%) andcyclopropanebutanoicacid,2-[[2-[[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]methyl]cyclopropyl]methyl]-, methyl ester  (2.3%). The chief bioactive compounds in petroleum ether soluble fraction were found to beandrost-8-en-3-ol, 4,4,14α-trimethyl-17-(2-bromo-1-methylethyl (57.9%), 14,17-nor-3,21-dioxo-β-amyrin, 17,18-didehydro-3-dehydroxy- (13.0%), barringtogenol B (2.5%), olean-12-ene-3,16,21,22,28-pentol, 21-(2-methyl-2-butenoate), [3β,16α,21β(Z),22α]-(1.7%),perhydrocyclopropa[e]azulene-4,5,6-triol, 1,1,4,6-tetramethyl  (1.7%), ethyl iso-allocholate (1.6%) and 1,2-benzenedicarboxylic acid, diisooctyl ester (1.6%). Both the extract and its fraction have exhibited very significant antibacterial, antifungal,mosquito repellent and larvicidal propertiesoriginated by numerous bioactive metabolites. Twenty eight (20 Gram-positive and 8 Gram-negative) bacteria were tested against LC.Me and LCM-PESwith noteworthy zone of inhibition.The significant in vitro antifungal activity was observed against fifteen fungi in LC-Me and LCM-PES. Very robust initial repellency was observed for LC-Me and LCM-PES (94% and 80% respectively) against the dengue-carrying mosquito (Aedes aegypti) at 2% concentration. The extract and its fraction were also found to be an efficient larvicidal agent against fourth-stage larvae of Aedes aegypti. The effective larvicidal property was noted in methanol soluble extract as compared topetroleum ether soluble fraction and standard with LC50value of 20 and 400 ppm respectively